Scarica l'app Stockscreener
4.23
11.32%
-0.54
Precedente Chiudi:
$4.77
Aprire:
$4.21
Volume 24 ore:
7,409
Relative Volume:
0.22
Capitalizzazione di mercato:
$7.82M
Reddito:
-
Utile/perdita netta:
$-7.03M
Rapporto P/E:
-0.4746
EPS:
-8.9134
Flusso di cassa netto:
$-8.20M
1 W Prestazione:
-23.09%
1M Prestazione:
-12.79%
6M Prestazione:
-29.03%
1 anno Prestazione:
+25.15%
Intervallo 1D:
$4.21
$4.52
Intervallo di 1 settimana:
$4.21
$5.63
Portata 52W:
$2.96
$11.96
Endra Life Sciences Inc Stock (NDRA) Company Profile
Nome
Endra Life Sciences Inc
Settore
Industria
Telefono
734-335-0468
Indirizzo
3600 GREEN COURT, ANN ARBOR, MI
Compare NDRA vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
4.23 | 8.82M | 0 | -7.03M | -8.20M | -8.9134 |
TMO
Thermo Fisher Scientific Inc
|
472.80 | 179.13B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
184.30 | 132.10B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
562.16 | 44.55B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
135.44 | 39.08B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
365.36 | 36.96B | 3.77B | 449.25M | 240.68M | 7.8556 |
Endra Life Sciences Inc Borsa (NDRA) Ultime notizie
ENDRA Life Sciences (NASDAQ: NDRA) Emerging Diagnostic - openPR.com
NDRA News | ENDRA LIFE SCIENCES INC (NASDAQ:NDRA) - ChartMill
NDRA Maintained by Ascendiant Capital -- Price Target Lowered to $25 - GuruFocus
Dell Technologies To Gain Nearly 79%? Here Are 10 Analyst Calls Investors Should Know - Benzinga
ENDRA Life Sciences Withdraws Filing for Securities Offering - Moomoo
ENDRA Life Sciences Inc. Announces Private Placement Securities Purchase Agreement and Issuance of Warrants – May 2026 - Minichart
ENDRA Life Sciences Announces Strategic Private Placement Financing - TipRanks
ENDRA Life Sciences Raises $3.8 Million in Private Placement; Sets Cash Safeguards in Side Letter - TradingView
ENDRA Life Sciences (NASDAQ: NDRA) raises $3.8M to bolster equity for Nasdaq - Stock Titan
Stocks to Watch: NDRA, SBFM, GOVX, HIVE, ANY Trading Actively NOW! - marketscreener.com
ENDRA Life Sciences (NASDAQ: NDRA) Beats Q1 Expectations, TAEUS - openPR.com
ENDRA Life Sciences Inc. announced that it expects to receive $3.800003 million in funding - marketscreener.com
[RW] ENDRA Life Sciences Inc. SEC Filing - Stock Titan
ENDRA Life Sciences NDRA Shows Modest Gains Testing Resistance at 573The Legal Advocate - The Legal Advocate
NDRA Q1 2026 Earnings: Wider-Than-Expected Loss as Pre-Revenue Stage ContinuesEarnings Manipulation Risk - Newser
ENDRA Life Sciences Q1 2026 Earnings: Wider-Than-Expected Loss as Pre-Revenue Biotech Continues DevelopmentUpward Estimate Revision - Newser
ENDRA Life Sciences Q1 2026 Earnings: EPS Misses Estimates as Development ContinuesQuarterly Financial Update - The Legal Advocate
ENDRA Life Sciences Inc.Common Stock (NQ: NDRA - The Chronicle-Journal
NDRA Stock Price, Quote & Chart | ENDRA LIFE SCIENCES INC (NASDAQ:NDRA) - ChartMill
Endra Life Sciences reports Q1 EPS ($1.09) vs. ($1.86) last year - TipRanks
NDRA Strengthens Clinical Foundation for TAEUS Liver Technology - GuruFocus
ENDRA Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update - Business Wire
ENDRA Life Sciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
ENDRA Life Sciences (NASDAQ: NDRA) faces Nasdaq equity notice after Q1 loss - Stock Titan
ENDRA Life Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
ENDRA Life (NDRA) Q4 2025 Results Miss Estimates — EPS $-3.26 vs $-1.25Expert Stock Picks - Newser
NDRA Q1'26 Earnings: EPS estimate is (1.23) USD - TradingView
Endra Life Sciences (NDRA) Achieves Promising Results with TAEUS Liver - GuruFocus
Endra Life Sciences reports multi-site validation of TAEUS Liver device - TipRanks
ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accu - PharmiWeb.com
ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accuracy and Reproducibility - BioSpace
ENDRA reports multi-site validation results for liver imaging device - Investing.com UK
ENDRA reports multi-site validation results for liver imaging device By Investing.com - Investing.com Australia
Liver Device Demonstrating MRI-like Accuracy and Reproducibility - Business Wire
TradingKey - TradingKey
ENDRA Life Sciences (NASDAQ: NDRA) Heats Up as Diagnostic Play - openPR.com
Is ENDRA Life (NDRA) stock suitable for your portfolio? (Nudges Down) 2026-04-27Senior Analyst Forecasts - Newser
ENDRA Life Sciences (NDRA) price target decreased by 10.00% to 27.54 - MSN
ENDRA Life (NDRA) Stock Chart | Q4 2025: Earnings Fall ShortFree Cash Margin - Xã Châu Thành
ENDRA Life Sciences Faces Renewed Nasdaq Listing Compliance Risk - The Globe and Mail
ENDRA Life Sciences Inc. Files Form 8-K with SEC – Company Details, Address, and Compliance Information (April 2026) 23 - Minichart
Endra Life Sciences receives Nasdaq delisting notice over equity requirement - Investing.com
Endra Life Sciences Inc Azioni (NDRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.13%
2.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):